Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MELA-PAED: Melatonin for Prevention of Postoperative Agitation and Emergence Delirium in Children
NCT05541276Phase 3Recruiting
- Start
- Jan 2025
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in emergence delirium (ED). Started Jan 2025; status: recruiting.
02
Drugs
melatonin
03
Conditions
emergence delirium (ED)
Beyond the preview
Go deeper on NCT05541276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05541276.